Responses to amyloids of microbial and host origin are mediated through toll-like receptor 2.
暂无分享,去创建一个
Andreas J Bäumler | B. Chromy | A. Bäumler | Cagla Tükel | R Paul Wilson | Jessalyn H Nishimori | Milad Pezeshki | Brett A Chromy | Ç. Tükel | R. Wilson | M. Pezeshki | Jessalyn H. Nishimori | R. Wilson
[1] Maria L. D. Udan,et al. Toll‐like receptors 2 and 4 mediate Aβ(1–42) activation of the innate immune response in a human monocytic cell line , 2007, Journal of neurochemistry.
[2] S. Normark,et al. Expression of and cytokine activation by Escherichia coli curli fibers in human sepsis. , 2000, The Journal of infectious diseases.
[3] R. Kingsley,et al. The use of flow cytometry to detect expression of subunits encoded by 11 Salmonella enterica serotype Typhimurium fimbrial operons , 2003, Molecular microbiology.
[4] D. Ferrari,et al. Activation of microglial cells by beta-amyloid protein and interferon-gamma. , 1995, Nature.
[5] C. Palencia,et al. Fibrillar Amyloid-β Peptides Activate Microglia via TLR2: Implications for Alzheimer’s Disease1 , 2008, The Journal of Immunology.
[6] M. Chapman,et al. In Vitro Polymerization of a Functional Escherichia coli Amyloid Protein* , 2006, Journal of Biological Chemistry.
[7] Scott J. Hultgren,et al. Role of Escherichia coli Curli Operons in Directing Amyloid Fiber Formation , 2002, Science.
[8] B. Holzmann,et al. Role of Toll-like receptor responses for sepsis pathogenesis. , 2008, Immunobiology.
[9] R. Tsolis,et al. Mice Lacking Components of Adaptive Immunity Show Increased Brucella abortus virB Mutant Colonization , 2007, Infection and Immunity.
[10] R. Hodges,et al. Structural predictions of AgfA, the insoluble fimbrial subunit of Salmonella thin aggregative fimbriae. , 1999, Journal of molecular biology.
[11] R. Ye,et al. Cutting Edge: TLR2 Is a Functional Receptor for Acute-Phase Serum Amyloid A1 , 2008, The Journal of Immunology.
[12] P. Vallance,et al. Effect of nitric oxide synthase inhibitors on hypotension in patients with septic shock , 1991, The Lancet.
[13] Adriana B Ferreira,et al. S100β Induces Neuronal Cell Death Through Nitric Oxide Release from Astrocytes , 1997, Journal of neurochemistry.
[14] D. Otzen,et al. We find them here, we find them there: Functional bacterial amyloid , 2008, Cellular and Molecular Life Sciences.
[15] A. Bäumler,et al. The Salmonella enterica Serotype Typhimurium lpf, bcf, stb, stc, std, and sth Fimbrial Operons Are Required for Intestinal Persistence in Mice , 2005, Infection and Immunity.
[16] H. Neumann,et al. LPS receptor (CD14): a receptor for phagocytosis of Alzheimer's amyloid peptide. , 2005, Brain : a journal of neurology.
[17] K. L. Richard,et al. Toll-Like Receptor 2 Acts as a Natural Innate Immune Receptor to Clear Amyloid β1–42 and Delay the Cognitive Decline in a Mouse Model of Alzheimer's Disease , 2008, The Journal of Neuroscience.
[18] R. Darveau,et al. A novel Escherichia coli lipid A mutant that produces an antiinflammatory lipopolysaccharide. , 1996, The Journal of clinical investigation.
[19] S. Opal,et al. The Toll-like receptors and their role in septic shock , 2003, Expert opinion on therapeutic targets.
[20] U. Gophna,et al. The formation of Escherichia coli curli amyloid fibrils is mediated by prion-like peptide repeats. , 2005, Journal of molecular biology.
[21] S. Rubino,et al. The Vi Capsular Antigen of Salmonella enterica Serotype Typhi Reduces Toll-Like Receptor-Dependent Interleukin-8 Expression in the Intestinal Mucosa , 2005, Infection and Immunity.
[22] S. Akira,et al. Differential roles of TLR2 and TLR4 in recognition of gram-negative and gram-positive bacterial cell wall components. , 1999, Immunity.
[23] Matthew R Chapman,et al. Curli biogenesis and function. , 2006, Annual review of microbiology.
[24] F. Heffron,et al. Ethanolamine utilization in Salmonella typhimurium: nucleotide sequence, protein expression, and mutational analysis of the cchA cchB eutE eutJ eutG eutH gene cluster , 1995, Journal of bacteriology.
[25] H. Andrews-Polymenis,et al. CsgA is a pathogen‐associated molecular pattern of Salmonella enterica serotype Typhimurium that is recognized by Toll‐like receptor 2 , 2005, Molecular microbiology.
[26] K. Ishii,et al. The LPS receptor (CD14) links innate immunity with Alzheimer's disease , 2004, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.
[27] K. Kataoka,et al. Lipopolysaccharide-induced microglial activation in culture: temporal profiles of morphological change and release of cytokines and nitric oxide , 1999, Neuroscience Research.
[28] P. Godowski,et al. Cell activation and apoptosis by bacterial lipoproteins through toll-like receptor-2. , 1999, Science.
[29] J. Adams,et al. Reversal of endotoxin-mediated shock by NG-methyl-L-arginine, an inhibitor of nitric oxide synthesis. , 1990, Biochemical and biophysical research communications.
[30] J. Weissman,et al. A census of glutamine/asparagine-rich regions: implications for their conserved function and the prediction of novel prions. , 2000, Proceedings of the National Academy of Sciences of the United States of America.
[31] S. Normark,et al. Fibronectin binding mediated by a novel class of surface organelles on Escherichia coll , 1989, Nature.
[32] T. Thomas,et al. Brucella requires a functional Type IV secretion system to elicit innate immune responses in mice , 2007, Cellular microbiology.
[33] E. Uemura,et al. Microglial release of nitric oxide by the synergistic action of β-amyloid and IFN-γ , 1995, Brain Research.
[34] U. Römling,et al. Production of Cellulose and Curli Fimbriae by Members of the Family Enterobacteriaceae Isolated from the Human Gastrointestinal Tract , 2003, Infection and Immunity.
[35] S. Normark,et al. Activation of inducible nitric oxide synthase/nitric oxide by curli fibers leads to a fall in blood pressure during systemic Escherichia coli infection in mice. , 2001, The Journal of infectious diseases.
[36] M. Perutz,et al. Aggregation of proteins with expanded glutamine and alanine repeats of the glutamine-rich and asparagine-rich domains of Sup35 and of the amyloid β-peptide of amyloid plaques , 2002, Proceedings of the National Academy of Sciences of the United States of America.
[37] J. Cunnick,et al. Microglial release of nitric oxide by the synergistic action of beta-amyloid and IFN-gamma. , 1995, Brain Research.
[38] I. Charles,et al. A lethal role for lipid A in Salmonella infections , 1998, Molecular microbiology.
[39] R. Ye,et al. Serum amyloid A induces G-CSF expression and neutrophilia via Toll-like receptor 2. , 2009, Blood.
[40] H. Levine,et al. Thioflavine T interaction with synthetic Alzheimer's disease β‐amyloid peptides: Detection of amyloid aggregation in solution , 1993, Protein science : a publication of the Protein Society.
[41] S. Winter,et al. The Vi‐capsule prevents Toll‐like receptor 4 recognition of Salmonella , 2008, Cellular microbiology.
[42] T. Town,et al. Journal of Neuroinflammation BioMed Central Review Involvement of β-chemokines in the development of inflammatory demyelination , 2005 .
[43] M. Chapman,et al. The curli nucleator protein, CsgB, contains an amyloidogenic domain that directs CsgA polymerization , 2007, Proceedings of the National Academy of Sciences.
[44] W. Schulz-Schaeffer,et al. Screening of innate immune receptors in neurodegenerative diseases: A similar pattern , 2009, Neurobiology of Aging.
[45] D. Otzen,et al. Amyloid adhesins are abundant in natural biofilms. , 2007, Environmental microbiology.
[46] C. Palencia,et al. Fibrillar amyloid-beta peptides activate microglia via TLR2: implications for Alzheimer's disease. , 2008, Journal of immunology.